Jaw osteoporosis: Challenges to oral health and emerging perspectives of treatment.
Liu F, Wang X, He Y, Han R, Wang T, Guo Y.
Biomed Pharmacother. 2024 Aug;177:116995. doi: 10.1016/j.biopha.2024.116995. Epub 2024 Jun 24.
PMID:38917761
Osteonecrosis of the jaw complicating bisphosphonate treatment for bone disease in multiple myeloma: an overview with recommendations for prevention and treatment.
Dickinson M, Prince HM, Kirsa S, Zannettino A, Gibbs SD, Mileshkin L, O'Grady J, Seymour JF, Szer J, Horvath N, Joshua DE.
Intern Med J. 2009 May;39(5):304-16. doi: 10.1111/j.1445-5994.2008.01824.x. Epub 2008 Nov 3.
PMID:19220531
[Osteonecrosis of the jaws].
Foncea C, von Bischhoffshausen K, Teuber C, Ramírez H, Goñi I, Sánchez C, Retamal IN, Vargas A.
Rev Med Chil. 2020 Jul;148(7):983-991. doi: 10.4067/S0034-98872020000700983.
PMID:33399683
Osteonecrosis of the jaw: what do bisphosphonates do?
Aspenberg P.
Expert Opin Drug Saf. 2006 Nov;5(6):743-5. doi: 10.1517/14740338.5.6.743.
PMID:17044800
Osteonecrosis of the jaw related to the use of bisphosphonates.